| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |